JP2025026461A5 - - Google Patents
Info
- Publication number
- JP2025026461A5 JP2025026461A5 JP2024193753A JP2024193753A JP2025026461A5 JP 2025026461 A5 JP2025026461 A5 JP 2025026461A5 JP 2024193753 A JP2024193753 A JP 2024193753A JP 2024193753 A JP2024193753 A JP 2024193753A JP 2025026461 A5 JP2025026461 A5 JP 2025026461A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- animal
- lawsonia intracellularis
- immune response
- protective immune
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063055947P | 2020-07-24 | 2020-07-24 | |
| US63/055,947 | 2020-07-24 | ||
| EP20196349 | 2020-09-16 | ||
| EP20196349.3 | 2020-09-16 | ||
| PCT/US2021/042778 WO2022020593A2 (en) | 2020-07-24 | 2021-07-22 | Combination porcine vaccine |
| JP2023504581A JP7657287B2 (ja) | 2020-07-24 | 2021-07-22 | 組合せブタワクチン |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504581A Division JP7657287B2 (ja) | 2020-07-24 | 2021-07-22 | 組合せブタワクチン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025026461A JP2025026461A (ja) | 2025-02-21 |
| JP2025026461A5 true JP2025026461A5 (enExample) | 2025-09-04 |
Family
ID=77274829
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504581A Active JP7657287B2 (ja) | 2020-07-24 | 2021-07-22 | 組合せブタワクチン |
| JP2024193753A Pending JP2025026461A (ja) | 2020-07-24 | 2024-11-05 | 組合せブタワクチン |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023504581A Active JP7657287B2 (ja) | 2020-07-24 | 2021-07-22 | 組合せブタワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230241198A1 (enExample) |
| EP (1) | EP4185321A2 (enExample) |
| JP (2) | JP7657287B2 (enExample) |
| KR (1) | KR20230044474A (enExample) |
| CN (1) | CN116157147A (enExample) |
| AU (1) | AU2021311726A1 (enExample) |
| BR (1) | BR112023001324A2 (enExample) |
| CA (1) | CA3185751A1 (enExample) |
| CL (1) | CL2023000118A1 (enExample) |
| CO (1) | CO2023000299A2 (enExample) |
| MX (1) | MX2023001024A (enExample) |
| WO (1) | WO2022020593A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116036260A (zh) * | 2022-12-30 | 2023-05-02 | 哈药集团生物疫苗有限公司 | 猪圆环病毒、猪肺炎支原体、猪塞内卡病毒三联灭活疫苗及其制备方法和应用 |
| WO2024260953A1 (en) * | 2023-06-23 | 2024-12-26 | Intervet International B.V. | A method of culturing lawsonia intracellularis bacteria |
| CN118894910A (zh) * | 2024-07-24 | 2024-11-05 | 华南农业大学 | 一种PRRSV-GP3-GP5-M+PCV2-TBCap重组蛋白、疫苗及应用 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
| DE3584341D1 (de) | 1984-08-24 | 1991-11-14 | Upjohn Co | Rekombinante dna-verbindungen und expression von polypeptiden wie tpa. |
| HU218431B (hu) | 1991-06-06 | 2000-08-28 | Stichting Centraal Diergeneeskundig Instituut | A rejtélyes sertésvészt okozó Lelystad-vírus, a vírusból származtatható polipeptidek, antigének és nukleinsavak és rejtélyes sertésvész elleni vakcinakészítmények |
| EP0601062B2 (en) | 1991-08-26 | 2000-12-13 | Regents Of The University Of Minnesota | Sirs vaccine and diagnosis method |
| US6042830A (en) | 1992-08-05 | 2000-03-28 | Boehringer Ingelheim Vetmedica, Inc. | Viral agent associated with mystery swine disease |
| AU2696792A (en) | 1991-09-16 | 1993-04-27 | David A Benfield | Vaccine for mystery swine disease and method for diagnosis thereof |
| ATE131067T1 (de) | 1991-10-14 | 1995-12-15 | Akzo Nobel Nv | Impfstoff gegen das fortpflanzungs- und atmungssyndrom bei schweinen (prrs) und diagnose. |
| DK0676467T3 (da) | 1994-04-11 | 2002-01-21 | Akzo Nobel Nv | Europæiske vaccinestammer af det porcine reproduktive respiratoriske syndromvirus (PRRSV) |
| US5788962A (en) | 1995-01-17 | 1998-08-04 | The Curators Of The University Of Missouri | DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures |
| ES2223058T3 (es) | 1995-03-14 | 2005-02-16 | Akzo Nobel N.V. | Expresion en la misma celula de polipeptidos del virus del sindrome reproductivo y respiratorio porcino. |
| US5885823A (en) | 1995-06-05 | 1999-03-23 | Nobl Laboratories, Inc. | Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| DK0835930T3 (da) | 1996-10-09 | 2001-06-18 | Akzo Nobel Nv | Europæiske vaccinestammer af porcint reproduktions- og respirationssyndrom-virus. (PRRSV) |
| US6391314B1 (en) | 1997-10-03 | 2002-05-21 | Merial | Porcine circoviruses vaccines diagnostic reagents |
| UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
| US6943152B1 (en) | 1999-06-10 | 2005-09-13 | Merial | DNA vaccine-PCV |
| RU2420570C2 (ru) * | 2003-07-25 | 2011-06-10 | Бёрингер Ингельхайм Ветмедика, Инк. | Lawsonia intracellularis ЕВРОПЕЙСКОГО ПРОИСХОЖДЕНИЯ И ВАКЦИНЫ, ДИАГНОСТИЧЕСКИЕ АГЕНТЫ НА ЕЕ ОСНОВЕ И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| US7833707B2 (en) | 2004-12-30 | 2010-11-16 | Boehringer Ingelheim Vetmedica, Inc. | Methods of overexpression and recovery of porcine circovirus type 2 ORF2 |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| HUE054868T2 (hu) * | 2005-12-29 | 2021-10-28 | Boehringer Ingelheim Animal Health Usa Inc | Multivalens PVC2 immunogén készítmények és eljárások ezek elõállítására |
| EP1976558B1 (en) | 2005-12-29 | 2017-03-15 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 immunogenic composition for lessening clinical symptoms in pigs |
| ES2726777T3 (es) | 2006-12-15 | 2019-10-09 | Boehringer Ingelheim Animal Health Usa Inc | Vacuna porcina anti-PCV2 en dosis única |
| WO2009126356A2 (en) | 2008-01-23 | 2009-10-15 | Boehringer Ingelheim Vetmedica, Inc. | Pcv2 mycoplasma hyopneumoniae immunogenic compositions and methods of producing such compositions |
| US8444989B1 (en) | 2008-04-18 | 2013-05-21 | Boehringer Ingelheim Vetmedica Gmbh | One dose vaccination against mycoplasma infections of pigs |
| CN103370077B (zh) | 2011-02-17 | 2016-10-26 | 贝林格尔.英格海姆维特梅迪卡有限公司 | 猪繁殖与呼吸综合征病毒的商业化规模生产方法 |
| BR122021013826B1 (pt) | 2011-02-17 | 2022-11-22 | Boehringer Ingelheim Vetmedica Gmbh | Composição de proteína, ácido nucleico isolado e vetor de expressão recombinante |
| US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
| AR097762A1 (es) | 2013-09-27 | 2016-04-13 | Intervet Int Bv | Formulaciones secas de vacunas que son estables a temperatura ambiente |
| TWI670085B (zh) * | 2014-02-19 | 2019-09-01 | 荷蘭商英特威國際公司 | 液體穩定之豬病毒疫苗 |
-
2021
- 2021-07-22 BR BR112023001324A patent/BR112023001324A2/pt unknown
- 2021-07-22 EP EP21752619.3A patent/EP4185321A2/en active Pending
- 2021-07-22 US US18/003,056 patent/US20230241198A1/en active Pending
- 2021-07-22 CA CA3185751A patent/CA3185751A1/en active Pending
- 2021-07-22 CN CN202180060299.8A patent/CN116157147A/zh active Pending
- 2021-07-22 MX MX2023001024A patent/MX2023001024A/es unknown
- 2021-07-22 KR KR1020237006573A patent/KR20230044474A/ko active Pending
- 2021-07-22 AU AU2021311726A patent/AU2021311726A1/en active Pending
- 2021-07-22 JP JP2023504581A patent/JP7657287B2/ja active Active
- 2021-07-22 WO PCT/US2021/042778 patent/WO2022020593A2/en not_active Ceased
-
2023
- 2023-01-12 CO CONC2023/0000299A patent/CO2023000299A2/es unknown
- 2023-01-12 CL CL2023000118A patent/CL2023000118A1/es unknown
-
2024
- 2024-11-05 JP JP2024193753A patent/JP2025026461A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025026461A5 (enExample) | ||
| CN101175509B (zh) | 含有胞内劳森菌的免疫原性组合物 | |
| Kwon et al. | Efficacy of oral immunization with Edwardsiella tarda ghosts against edwardsiellosis in olive flounder (Paralichthys olivaceus) | |
| JP5257901B2 (ja) | ローソニア・イントラセルラリス感染に対する幼若動物のワクチン接種 | |
| Shewen et al. | Challenges in mucosal vaccination of cattle | |
| AU2013370982C9 (en) | Immunogenic composition comprising mycoplasma antigens | |
| JP2010510197A (ja) | ワクチンの製造のためのクロストリジウム・パーフリンジェンスｃ型細菌の使用 | |
| Shin et al. | Effective methods for the production of immunoglobulin Y using immunogens of Bordetella bronchiseptica, Pasteurella multocida and Actinobacillus pleuropneumoniae | |
| JP2021535138A (ja) | 混合ワクチン | |
| Van den Broeck et al. | Seroprevalence of F4+ enterotoxigenic Escherichia coli in regions with different pig farm densities | |
| US20180193441A1 (en) | Swine dysentery vaccine | |
| CN101541343B (zh) | C型产气荚膜梭菌用于制备疫苗的用途 | |
| Abodalal et al. | Preparation of locally prepared inactivated combined vaccine of rabbit hemorrhagic disease virus types 1 & 2 and Pasteurella multocida. | |
| Sturbelle et al. | The use of quorum sensing to improve vaccine immune response | |
| Smith et al. | The immunity produced by a rough Salmonella dublin variant against Salmonella typhimurium and Salmonella choleraesuis infection in guinea-pigs | |
| WO2019081583A1 (en) | VACCINE AGAINST SINGLE STEM DYSENTERY | |
| Yousafzai et al. | IMPROVING MCCP VACCINE IN SHEEP: NOVEL STRATEGIES FOR DEVELOPMENT, EFFICACY AND CROSS-PROTECTION | |
| JP2020522471A (ja) | クロストリジウム類毒素を含むワクチン | |
| Zyan et al. | Field trial to evaluate the efficacy of aluminium hydroxide gel (Alv) rabbit pasteurella vaccine in rabbits | |
| El-Sayed et al. | Efficacy of the E. Coli whole cell lysates for improving immunogenic quality of the local entero-3 vaccine | |
| Valpotić et al. | Evaluation of the prophylactic potential of non-enterotoxigenic Escherichia coli (non-ETEC) vaccine immunization and dietary mannan oligosaccharide competitive exclusion benefits against ETEC infections in weaned pigs | |
| Done | Enteric and respiratory diseases in the young weaned piglet. | |
| CALVES | JS Cullor, B. Fenwick, BP Smith, K. Pelzer, A. Kelly, and BI Osburn Department of Veterinary Pathology | |
| CN106421777A (zh) | 白藜芦醇作为疫苗佐剂的应用 | |
| Elsheikha et al. | Therapeutic efficacy of chicken egg yolk immunoglobulins against Mycoplasma gallisepticum infection in chickens |